You are here

"Diamonds are forever ... ", report from ASCO


Diamonds Are Forever, but TKIs in CML Don't Have to Be

Alexander M. Castellino, PhD

June 06, 2019

"Treatment-free remission is a reality," he said. He indicated that greater success is achieved when remissions are deeper and more durable. A minimum of 2 years of treatment with a TKI may be sufficient, but the chances of achieving deeper molecular remissions are higher with 5 years of treatment, he suggested.